Tilray, Inc. (NASDAQ: TLRY) Investor Securities Class Action Lawsuit 03/06/2020

If you purchased a significant amount of shares of Tilray, Inc. (NASDAQ: TLRY), you have certain options and for certain investors are short and strict deadlines running. Deadline: May 5, 2020. NASDAQ: TLRY investors should contact the Shareholders Foundation, Inc.

To have your information reviewed for options and to recieve notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Company Name(s): 
Case Name: 
Tilray Shareholder Class Action Lawsuit 03/06/2020
Case Status: 
Lawsuit Filed
Affected Securities
Lawsuit Overview
Type of Lawsuit: 
Shareholder Class Action
Date Filed: 
Class Period Begin: 
Class Period End: 
Court of Filing: 
U.S. District Court for the Eastern District of New York
Deadline To File for Lead: 

An investor in shares of Tilray, Inc. (NASDAQ: TLRY) filed a lawsuit in the U.S. District Court for the Eastern District of New York over alleged violations of Federal Securities Laws by Tilray, Inc. in connection with certain allegedly false and misleading statements made between January 15, 2019 and March 2, 2020.
Canada based Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis.

On January 15, 2019, Tilray, Inc. announced its entry into a marketing and revenue sharing agreement with Authentic Brands Group (“ABG”), “an owner of a portfolio of global lifestyle and entertainment brands” (the “ABG Agreement”).

On March 2, 2020, Tilray, Inc. announced the Company’s financial results for the fourth quarter and full year 2019. Among other results, Tilray, Inc. reported a net loss for the year of $321.2 million, or $3.20 per share, compared to $67.7 million, or $0.82 per share, for 2018. In addition, Tilray disclosed that “the Company recorded non-cash charges of $112.1 million related to impairment of the Authentic Brands Group LLC (‘ABG’) agreement as well as $68.6 million in inventory reserves.”

Shares of Tilray, Inc. (NASDAQ: TLRY) declined from $21.09 per share on February 20, 2020 to as low as $7.67 per share on March 9, 2020.

According to the complaint the plaintiff alleges on behalf of purchasers of Tilray, Inc. (NASDAQ: TLRY) common shares between January 15, 2019 and March 2, 2020, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between January 15, 2019 and March 2, 2020, the defendants made false and/or misleading statements and/or failed to disclose that the purported advantages of the ABG Agreement were significantly overstated, that the underperformance of the ABG Agreement would foreseeably have a significant impact on the Company’s financial results, and that as a result, the Company’s public statements were materially false and misleading at all relevant times.